SOPHiA GENETICS
Boston
About SOPHiA GENETICS
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $265.2M
- Funding stage: IPO
- Last round: Post-IPO Debt (May 2024)
- Ticker: nasdaq:SOPH
- Website: sophiagenetics.com
- Phone: +1 617 982 1210
Industries & Categories
Artificial Intelligence (AI), Big Data, Bioinformatics, Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/sophia-genetics-11432 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.